COVID-19 Vaccination Guidelines for MS Patients
Published on Wed, 25 Aug 2021

MENACTRIMS practice guideline for COVID-19 vaccination in patients with multiple sclerosis
The MENACTRIMS practice guideline recommends COVID-19 vaccination for all multiple sclerosis (MS) patients, emphasizing that vaccines are effective and pose no additional risks. Patients on disease-modifying therapies (DMTs) may experience slightly reduced vaccine efficacy, but coordination of vaccine timing with certain DMTs can optimize protection. Despite vaccination, MS patients should continue preventive measures like wearing masks and social distancing. The guideline assures the safety of mRNA, non-replicating viral vector, inactivated virus, and protein vaccines, prioritizing patient protection against COVID-19.